
Keywords: cis-diamminedichloroplatinum (II); ABC proteins; ATP-binding cassette proteins; cDDP; cis-diamminedichloroplatinum(II); DOX; doxorubicin; ECn; effective concentration at which n% of control is active; EDTA; ethylenediaminetetraacetic acid; HEPES; 4-(2-hydroxyethyl)-1-piperazineethanesulfon